SCHEMBL7686

SCHEMBL7686

O=C(OC(C(=O)O)(C(=O)c1ccccc1)C(O)C(=O)O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.43
TP53 P04637 1/20 0.43
LMNA P02545 2/20 0.41
F2 P00734 1/20 0.41
ALDH1A1 P00352 4/20 0.41
CES1 P23141 2/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 5/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
SRC P12931 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
KMT2A Q03164 3/20 0.35
MAPT P10636 3/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221679 1.00 TSHR (0.43) TSHRTP53LMNAF2ALDH1A1
SCHEMBL27362899 1.00 TSHR (0.43) TSHRTP53LMNAF2ALDH1A1
SCHEMBL2904556 1.00 TSHR (0.43) TSHRTP53LMNAF2ALDH1A1
SCHEMBL223031 1.00 TSHR (0.43) TSHRTP53LMNAF2ALDH1A1
SCHEMBL1483657 1.00 TSHR (0.43) TSHRTP53LMNAF2ALDH1A1
SCHEMBL3946464 0.98 TSHR (0.42) TSHRTP53LMNAF2ALDH1A1
Water SCHEMBL1818831 0.98 TSHR (0.42) TSHRTP53LMNAF2ALDH1A1
Water SCHEMBL789812 0.98 TSHR (0.42) TSHRTP53LMNAF2ALDH1A1
Ammonia Solution, Strong SCHEMBL11444698 0.98 TSHR (0.42) TSHRTP53LMNAF2ALDH1A1
SCHEMBL11542849 0.98 TSHR (0.42) TSHRTP53LMNAF2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 15655 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103747-A1 SALT OF THIAZOLE DERIVATIVE INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF 江苏豪森药业集团有限公司 2026-05-21 WO claimed
CN-122036704-A Free base crystal form or acid salt of biaryl compound, preparation method and medical application thereof 江苏豪森药业集团有限公司 2026-05-15 CN claimed
US-12624050-B2 Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2026-05-12 US claimed
EP-2556187-B1 ORGANIC-INORGANIC HYBRID NANOFIBRES HAVING A MESOPOROUS INORGANIC PHASE, PREPARATION THEREOF BY ELECTRICALLY ASSISTED EXTRUSION, MEMBRANE, ELECTRODE AND FUEL CELL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2026-05-06 EP claimed
EP-4721739-A1 CSF-1R INHIBITOR PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2026-04-08 EP claimed
EP-4265604-B1 OXASPIRO SUBSTITUTED PYRROLOPYRAZOLE DERIVATIVE, INTERMEDIATE THEREOF, AND PREPARATION METHOD THEREFOR SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD (CN) 2026-04-01 EP claimed
CN-121586715-A Salt and crystal forms of methionine adenosine transferase 2A heterocyclic inhibitor and preparation method thereof 南京正大天晴制药有限公司 2026-02-27 CN claimed
US-12551465-B2 Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition CELLTRION INC. (KR) 2026-02-17 US claimed
US-20260015355-A1 METHOD FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1-6-NAPHTHYRIDINE-3-CARBOX-AMIDE BY RACEMATE SEPARATION BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS BAYER AKTIENGESELLSCHAFT (DE) 2026-01-15 US claimed
EP-3606525-B1 COMPOSITIONS FOR TREATING AGING-ASSOCIATED IMPAIRMENTS USING CCR3-INHIBITORS ALKAHEST INC (US) 2025-12-10 EP claimed
WO-1990012790-A1 PYRIMIDINE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-11-01 WO claimed
US-4952683-A WOUND HEALING AGENTS SOLCO BASEL AG (CH) 1990-08-28 US claimed
EP-0141408-B1 PROCESS FOR THE PREPARATION OF L(-)CARNITINE HYDROCHLORIDE AND OF L(-)CARNITINE INNER SALT ISOM S.p.A. (IT) 1989-08-23 EP claimed
EP-0204481-A2 Process for optically active threo-3-(3,4-methylenedioxyphenyl) serine SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1986-12-10 EP claimed
EP-0074903-B1 DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE, THEIR PREPARATION AND THEIR THERAPEUTIC USE SYNTHELABO (FR) 1986-11-05 EP claimed
EP-0082364-B1 (+)-2-(1-(2,6-DICHLOROPHENOXY)-ETHYL)-1,3-DIAZACYCLOPENT-2-ENE, PROCESS FOR ITS PREPARATION AND ITS USE IN PHARMACEUTICAL COMPOSITIONS A. Nattermann & Cie. GmbH (DE) 1986-04-23 EP claimed
EP-0141408-A2 Process for the preparation of L(-)carnitine hydrochloride and of L(-)carnitine inner salt ISOM S.p.A. (IT) 1985-05-15 EP claimed
US-4294838-A ANTIBRONCHOSPASMOLYTIC AGENTS WARNER-LAMBERT COMPANY, A CORP. OF DE 1981-10-13 US claimed
US-4183865-A SALT FORMATION WITH (-)DIBENZOYL TARTARIC ACID IN A POLAR SOLVENT KRKA, FARMACEVTIKA, KEMIJA, KOZMETIKA, ZDRAVILISCA IN GOSTINSTVO, NOVO MESTO, N.SOL.O. (YU) 1980-01-15 US claimed
US-4072698-A OPTICALLY ACTIVE ACIDS WITH KETONE OR ALDEHYDE CATALYST THE UPJOHN COMPANY (US) 1978-02-07 US claimed